Takeda

In the Know: Healthcare News for June 22, 2020

U.S. News and World Report Names Mayo Nation’s Top Hospital Medtronic gets $337 million from Blackstone for diabetes devices Abbott FreeStyle Libre 2 iCGM FDA cleared for use in adults and children At the Edge of Possible Cardiovascular Systems’ offering nabs $143.7m Mayo Clinic, NASA team up to test AI algorithm on colorectal cancer Boston […]

Takeda Expands Patient Assistance in the U.S. During COVID-19 Crisis

Via Takeda To our valued patients, customers and other stakeholders, As the COVID-19 crisis continues to unfold, Takeda’s Patient Assistance Response team is working around the clock to help ensure that the people who need our medicines and treatments can continue to access them safely and without interruption. Consistent with our commitment to prioritizing patients’ […]

You Survived COVID-19, You Could Help Others Do the Same

Via Takeda “Experts from the world’s leading plasma companies have come together to create a new alliance aimed at treating the new coronavirus. The CoVIg-19 Plasma Alliance is an initiative to accelerate the development of a potential treatment for COVID-19. The first phase of the Alliance is collecting plasma at licensed plasma collection centers across […]

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

Via Takeda Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one, unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobulin medicine with the potential to treat individuals with […]

Takeda Eyes Plasma Therapy for Covid-19 Patients

Via The Street “Japanese drug maker Takeda is planning to use an old therapy technology for a new disease, Covid-19. The company is developing a plasma-derived therapy, dubbed TAK-888, that would be similar to plasma-based treatments previously used on other severe acute viral infections, including during the Ebola crisis, that is based on technology believed to […]

In the Know: Healthcare News for March 9, 2020

COVID-19: How Mayo Clinic is preparing to respond to a potential pandemic Vice President Mike Pence visits 3M on coronavirus tour Takeda Pharma says it is developing coronavirus drug Coronavirus – How Health Plans Can Help Their Members Stay Safe from COVID-19 Right Now CE Mark for Abbott’s FlexNav Delivery System for TAVI Valve Sanofi […]

In The Know: Healthcare News for March 2, 2020

PhysIQ and U.S. Veteran’s Affairs Publish Breakthrough Study Takeda Takes Aim at Becoming World Leader in Treating Celiac and Other GI Disorders Abilitech aims to arm people with independence Medtronic names its first chief inclusion and diversity officer Cleveland Clinic spinout Cardionomic raises $16 million Abbott touts real-world data around FreeStyle Libre system gBETA Medtech […]

In the Know: Healthcare News for February 17, 2010

Carrot Health Named Top Innovator in Accenture HealthTech Innovation Challenge Nference Poised for Growth Following Mayo Clinic Investment, Partnership Minnesota Partnership Awards Leverage Top Experts Against Disease Medtronic to bolster its AI, surgical robotics work with Digital Surgery acquisition Takeda Pharmaceuticals invests in data management platform Seqster Medtronic and the Medtronic Foundation Commit More Than […]

In the Know: Healthcare News for November 11, 2019

Stryker announces definitive agreement to acquire Wright Medical for $5.4 Billion Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer Maple Grove-based Pursuit Vascular sold for $75 million to California firm Digi International spends $140 million to buy New Jersey IT company In $660 Million Deal, Takeda […]

In the Know — Healthcare News for May 27, 2019

Apple Watch app for nightmare disorder receives FDA breakthrough designation, opens enrollment for two RCTs MagStim wins FDA nod, launches StimGuide TMS navigation system Buoyed by CGT growth, Bio-Techne plans plant to supply $200m of reagents Minneapolis med-tech firm SynerFuse raises $2.6M FDA Approves Extension of Treatment for Short Bowel Syndrome to Include Children Strategic […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER